Monkeypox: Vaccination

Department of Health and Social Care written question – answered on 22nd September 2022.

Alert me about debates like this

Photo of Anneliese Dodds Anneliese Dodds Party Chair, Labour Party, Chair of Labour Policy Review, Shadow Secretary of State for Women and Equalities

To ask the Secretary of State for Health and Social Care, when the UK Health Security Agency plans to release its assessment of the efficacy of fractional dosing in vaccination against monkeypox as a means of addressing the discrepancy in estimated doses of vaccination that are required; and is she will make a statement.

Photo of Dr Caroline Johnson Dr Caroline Johnson The Parliamentary Under-Secretary for Health and Social Care

In August 2022, following the emergency use approval by the United States Food and Drug Administration, the UK Health Security Agency (UKHSA) and Joint Committee on Vaccination and Immunisation endorsed the use of a fractional dose of the vaccines used for monkeypox given by intradermal injection during periods of supply constraints.

Under the approach, eligible people are offered a 0.1 millilitre (ml) dose of the vaccines, instead of the 0.5ml dose typically administered. This will potentially enable up to a five-fold increase in the number of people that can be offered vaccination. NHS England and the UKHSA are currently assessing the operational feasibility of using fractional dosing, including necessary staffing model, vaccination throughput, volume and patient experience.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.